Piper Sandler analyst Matt O’Brien downgraded Sight Sciences to Neutral from Overweight with a price target of $5.50, down from $15.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SGHT:
- Sight Sciences (NASDAQ:SGHT) Tanks 31% After Slashing Outlook
- Sight Sciences falls over 20% after revenue guidance miss
- Sight Sciences appoints Matthew Link as chief commercial officer
- Sight Sciences lowers FY 23 revenue view to $80M-$82M from prior $89M -$94M
- Sight Sciences Appoints Matt Link as Chief Commercial Officer